Send to

Choose Destination
J Cardiovasc Thorac Res. 2016;8(1):40-2. doi: 10.15171/jcvtr.2016.07. Epub 2016 Mar 15.

Device closure in adults with atrial septal defect in Shiraz, a single center registry.

Author information

Cardiovascular Research Center, Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Master of Management, School of Management and Information, Shiraz University of Medical Sciences, Shiraz, Iran.



Successful closure of atrial septal defect (ASD) improves patients' functional class and exercise capacity. In this study we evaluate the safety and feasibility of percutaneous device closure of ASDs.


Two hundred fifty six patients with significant ASD according to our criteria were enrolled. The patients were treated using nitinol wire mesh transcatheter devices. Complications were followed for a median of 2.5 years.


Success rate was 98.4% with 3 unsuccessful cases and a mean hospital stay of 1.007 ± 0.0004 days. Complication rate was 7.42%. Size of the right ventricle (RV) annulus was significantly decreased 24 hours after intervention (P = 0.005).


The present report demonstrates that transcatheter closure of ASD is safe and effective.


ASD Devices; Atrial Septal Defect; Complications; Surgical Closure; Transcatheter Closure

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center